COO, CFO and Secretary
Tue, Nov 15, 2022
Nov 15
1,375 shares @ $0.00
Decreased holdings by -7.70%
Net across this filing: +0.30% (+945 shares)
89th largest trade (out of 143)
Option Exercise
Trade made by an officer
Sale tied to a same-time option exercise
Net holdings across this filing: +0.3% (+945 shares)
50% win rate · -2.6% median edge vs SPY (8 trades, 90-day · small sample)
Price 38% above 200-day moving average
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology